DE69233093D1 - Substituierte phenserine und phenylcarbamate von (-)-eserolin, (-)-n1-noreserolin und (-)-n1-benzylnoresorolin als spezifische acetylcholinesterase-inhibitoren - Google Patents
Substituierte phenserine und phenylcarbamate von (-)-eserolin, (-)-n1-noreserolin und (-)-n1-benzylnoresorolin als spezifische acetylcholinesterase-inhibitorenInfo
- Publication number
- DE69233093D1 DE69233093D1 DE69233093T DE69233093T DE69233093D1 DE 69233093 D1 DE69233093 D1 DE 69233093D1 DE 69233093 T DE69233093 T DE 69233093T DE 69233093 T DE69233093 T DE 69233093T DE 69233093 D1 DE69233093 D1 DE 69233093D1
- Authority
- DE
- Germany
- Prior art keywords
- noreserolin
- benzylnoresorolin
- eserolin
- phenserine
- phenylcarbamate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/765,746 US5171750A (en) | 1991-09-26 | 1991-09-26 | Substituted phenserines as specific inhibitors of acetylcholinesterase |
US86132992A | 1992-03-31 | 1992-03-31 | |
PCT/US1992/008228 WO1993006105A1 (en) | 1991-09-26 | 1992-09-28 | Substituted phenserines and phenylcarbamates of (-)-eseroline, (-)-n1-noreseroline, and (-)-n1-benzylnoreseroline; as specific inhibitors of acetylcholinesterase |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69233093D1 true DE69233093D1 (de) | 2003-07-10 |
DE69233093T2 DE69233093T2 (de) | 2003-12-18 |
Family
ID=27117645
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69233093T Expired - Fee Related DE69233093T2 (de) | 1991-09-26 | 1992-09-28 | Substituierte phenserine und phenylcarbamate von (-)-eserolin, (-)-n1-noreserolin und (-)-n1-benzylnoresorolin als spezifische acetylcholinesterase-inhibitoren |
Country Status (10)
Country | Link |
---|---|
US (1) | US5998460A (de) |
EP (1) | EP0606366B1 (de) |
JP (1) | JP3708957B2 (de) |
AT (1) | ATE242244T1 (de) |
AU (1) | AU674130B2 (de) |
CA (1) | CA2119783C (de) |
DE (1) | DE69233093T2 (de) |
DK (1) | DK0606366T3 (de) |
ES (1) | ES2201050T3 (de) |
WO (1) | WO1993006105A1 (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5932780A (en) * | 1994-02-28 | 1999-08-03 | Yissum Research Development Company Of Hebrew University Of Jerusalem | Transgenic non-human animal assay system for anti-cholinesterase substances |
US5338739A (en) * | 1994-03-10 | 1994-08-16 | Hoechst-Roussel Pharmaceuticals Inc. | (Pyrrolidinyl)phenyl carbamates, compositions and use |
BR9806184A (pt) * | 1997-07-09 | 2001-06-19 | Axonyx | Inibidores de butirilcolinesterase altamente seletivos para o tratamento e o diagnóstico da doença de alzheimer e demências |
US6534541B1 (en) | 1999-10-19 | 2003-03-18 | Novartis Ag | Treatment of ocular disorders |
US6495700B1 (en) | 2002-01-09 | 2002-12-17 | Axonyx, Inc. | Process for producing phenserine and its analog |
DE10301851A1 (de) * | 2003-01-17 | 2004-07-29 | Lts Lohmann Therapie-Systeme Ag | Verfahren zur medikamentösen Prophylaxe gegen Vergiftungen durch Cholinesterase-Hemmer, sowie hierfür geeignete Wirkstoffe und Arzneimittel |
DK2210605T3 (en) * | 2003-11-04 | 2017-05-22 | Tcd Royalty Sub Llc | Daily single dose doses of trospium. |
JP2007519738A (ja) * | 2004-01-30 | 2007-07-19 | アクソニクス,インコーポレイテッド | 糖尿病の合併症の治療方法 |
US20050182044A1 (en) * | 2004-02-17 | 2005-08-18 | Bruinsma Gosse B. | Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate |
CA2508585A1 (en) * | 2004-06-01 | 2005-12-01 | Axonyx, Inc. | Transdermal delivery system for treatment of cognitive disorders |
EP1604686A1 (de) * | 2004-06-08 | 2005-12-14 | Axonyx, Inc. | Verwendung von Phenserine und einem HMG CoA reduktase Hemmer zur Verzögerung der Alzheimer Krankheit |
WO2006138385A2 (en) * | 2005-06-14 | 2006-12-28 | Cancog Technologies Inc.24 | Use of phenserine and analogs to treat behavioral problems and improve trainability |
SG178773A1 (en) * | 2006-11-13 | 2012-03-29 | Ateris Technologies Llc | Pesticide biomarker |
US20110166043A1 (en) * | 2007-11-14 | 2011-07-07 | Jon Owen Nagy | Biomarker detection-2 |
US8772345B2 (en) | 2011-08-03 | 2014-07-08 | Southwest Research Institute | Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors |
US8653108B1 (en) * | 2011-08-03 | 2014-02-18 | Southwest Research Institute | Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors |
WO2014113495A1 (en) | 2013-01-15 | 2014-07-24 | The Trustees Of Columbia University In The City Of New York | Activation or reactivation of ache |
US9162983B2 (en) | 2013-05-22 | 2015-10-20 | Southwest Research Institute | Reactivators of organophosphorous inhibited acetylcholinesterase |
US10111860B1 (en) | 2016-01-15 | 2018-10-30 | Aristea Translational Medicine Corporation | Compositions and methods for treating concussion |
US10864192B2 (en) | 2016-01-15 | 2020-12-15 | Aristea Translational Medicine Corporation | Compositions and methods for inhibiting brain trauma-induced neurodegeneration and related conditions |
US20230113944A1 (en) * | 2020-01-10 | 2023-04-13 | The Regents Of The University Of California | Compositions and methods for the treatment of neurodegenerative diseases |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1199076B (it) * | 1984-03-01 | 1988-12-30 | Consiglio Nazionale Ricerche | Derivati della fisostigmina con proprieta'di inibizione della aceticolinesterasi e relativo procedimento di produzione |
US4791107A (en) * | 1986-07-16 | 1988-12-13 | Hoechst-Roussel Pharmaceuticals, Inc. | Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use |
US4900748A (en) * | 1988-03-04 | 1990-02-13 | The United States Of America As Represented By The Department Of Health And Human Services | Carbamates related to (-)-physostigmine as cholinergic agents |
US4914102A (en) * | 1989-09-28 | 1990-04-03 | Hoechst Roussel Pharmaceuticals, Inc. | N-aminocarbamates related to physostigmine, pharmacentical compositions and use |
-
1992
- 1992-09-28 JP JP50640593A patent/JP3708957B2/ja not_active Expired - Fee Related
- 1992-09-28 EP EP92921255A patent/EP0606366B1/de not_active Expired - Lifetime
- 1992-09-28 AT AT92921255T patent/ATE242244T1/de not_active IP Right Cessation
- 1992-09-28 DE DE69233093T patent/DE69233093T2/de not_active Expired - Fee Related
- 1992-09-28 ES ES92921255T patent/ES2201050T3/es not_active Expired - Lifetime
- 1992-09-28 DK DK92921255T patent/DK0606366T3/da active
- 1992-09-28 WO PCT/US1992/008228 patent/WO1993006105A1/en active IP Right Grant
- 1992-09-28 AU AU27544/92A patent/AU674130B2/en not_active Ceased
- 1992-09-28 CA CA002119783A patent/CA2119783C/en not_active Expired - Fee Related
-
1993
- 1993-07-26 US US08/096,207 patent/US5998460A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DK0606366T3 (da) | 2003-10-06 |
CA2119783C (en) | 2006-02-07 |
CA2119783A1 (en) | 1993-04-01 |
DE69233093T2 (de) | 2003-12-18 |
ES2201050T3 (es) | 2004-03-16 |
US5998460A (en) | 1999-12-07 |
ATE242244T1 (de) | 2003-06-15 |
WO1993006105A1 (en) | 1993-04-01 |
EP0606366A1 (de) | 1994-07-20 |
EP0606366B1 (de) | 2003-06-04 |
JPH07503703A (ja) | 1995-04-20 |
JP3708957B2 (ja) | 2005-10-19 |
AU2754492A (en) | 1993-04-27 |
AU674130B2 (en) | 1996-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69233093D1 (de) | Substituierte phenserine und phenylcarbamate von (-)-eserolin, (-)-n1-noreserolin und (-)-n1-benzylnoresorolin als spezifische acetylcholinesterase-inhibitoren | |
DE69736441D1 (de) | Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen | |
AP1697A (en) | Azabicycloalkanes as CCR5 modulators. | |
HUP0000558A2 (hu) | Aktív D-vitamin analógok alkalmazása prosztatabetegségek kezelésére szolgáló gyógyszerkészítmények előállítására | |
AP2001002187A0 (en) | Piperidines as CCR5 modulators. | |
DK1346041T3 (da) | Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom | |
ATE177949T1 (de) | Kombinationstherapie zur prophylaxe und/oder behandlung benigner prostatahyperplasie | |
MY132529A (en) | Paroxetine hydrochloride anhydrate | |
NO20101190L (no) | Anvendelse av buprenorfin i fremstillingen av et medikament | |
DK0975595T3 (da) | Kokainanaloger | |
UA19171A (uk) | Спосіб одержаhhя фіhілалкіламіhів або їх фармакологічhо прийhятhих солей | |
DK1187617T3 (da) | Fremgangsmåde til at vælge koncentrationen af et amfipatisk antihistaminlægemiddel ved at bestemme lægemidlets overfladeaktivitetsmåltal | |
DE69717148T2 (de) | 3-pyridylenantiomere und ihre verwendung als analgetika | |
LV12291A (lv) | Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai | |
DK0837935T3 (da) | Den 3'-ikke-translaterede region af det humane prohibitin-gen | |
NO993275D0 (no) | FremgangsmÕte ved terapeutisk administrering av anti-CD40L-forbindelser | |
ATE220904T1 (de) | 2-phenyl-3-azoylbenzothiophene zur erhöhung der thrombomodulin expression | |
CA2119782A1 (en) | Carbamate analogs of thiaphysovenine, pharmaceutical compositions, and method for inhibiting cholinesterases | |
HK1029937A1 (en) | Use of phanquinone for the treatment of alzheimer s disease. | |
NO20000519L (no) | 2-acylaminopropanaminer som takykininreseptorantagonister | |
DK675389A (da) | Terapeutiske praeparater til forebyggelse af fibrinaflejringer | |
HUP0100611A2 (hu) | Triazin vegyületek, és ilyeneket tartalmazó gyógyszerkészítmények a központi idegrendszer elváltozásainak kezelésére | |
HUP0000110A2 (hu) | Azaciklusos, azabiciklusos vagy tetrahidropiridinszármazékokat tartalmazó, fájdalom kezelésére alkalmas gyógyászati készítmények | |
LV11940A (lv) | Melatonina pielietojums personu arstesanai kuras cies no zalu atkaribas | |
EP0758312A4 (de) | Substituierte kondensierte und verbrückte bicyclische verbindungen als therapeutische mittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |